Novartis AG Revenue 2010-2024 | NVS

Novartis AG revenue for the twelve months ending September 30, 2024 was $49.940B, a 19.87% increase year-over-year.

  • Novartis AG annual revenue for 2023 was $46.66B, a 7.36% increase from 2022.
  • Novartis AG annual revenue for 2022 was $43.461B, a 17.81% decline from 2021.
  • Novartis AG annual revenue for 2021 was $52.877B, a 5.97% increase from 2020.

Novartis AG Revenue 2010-2024 | NVS

  • Novartis AG annual revenue for 2023 was $46.66B, a 7.36% increase from 2022.
  • Novartis AG annual revenue for 2022 was $43.461B, a 17.81% decline from 2021.
  • Novartis AG annual revenue for 2021 was $52.877B, a 5.97% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B